CD36 is, quantitatively, the most important scavenger receptor for uptake of oxidized lipoproteins by hepatocytes, and previous studies have shown that its upregulation is associated with insulin resistance, hyper-insulinemia, and increased steatosis in patients with NASH. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatohepatitis.